AbbVie, Genmab get FDA approval for blood cancer therapy
HQ Team May 20, 2023: AbbVie Inc and Danish drugmaker, Genmab, announced they have got FDA’s approval for a therapy to treat blood
Researchers are working on developing sustainable, zero-carbon fuels using photosynthesis to create artificial leaves to produce biofuel.
Researchers say the hormone estrogen causes a molecular dysfunction by altering a cell’s DNA and causing the breast tissue to develop.
Pfizer suspends sale of 4 antibiotics in India as there are some deviations observed in the manufacturing process
“Global mean temperatures are predicted to continue increasing, moving us away further and further away from the climate we are used to."